Androgen receptor CAG tract heterogeneity in benign and malignant prostatic glands

被引：0
|
作者：
Sircar, K
Alam-Fahmy, M
Aprikian, A
Beitel, L
Gottlieb, B
Trifiro, M
Alvarado, C
机构：
[1] McGill Univ, Ctr Hlth, Montreal, PQ H3A 2T5, Canada
[2] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada
来源：
MODERN PATHOLOGY | 2005年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
760
引用
收藏
页码：164A / 165A
页数：2
相关论文
共 50 条
  • [21] HETEROGENEITY OF ANDROGEN RECEPTOR DISTRIBUTION IN HUMAN BENIGN PROSTATIC HYPERPLASIA DEMONSTRATED USING A NEW METHOD OF STEROID-RECEPTOR AUTORADIOGRAPHY
    PETERS, CA
    BARRACK, ER
    JOURNAL OF UROLOGY, 1986, 135 (04): : A109 - A109
  • [22] ANDROGEN RECEPTOR HETEROGENEITY IN HUMAN PROSTATIC CARCINOMAS VISUALIZED BY IMMUNOHISTOCHEMISTRY
    DEWINTER, JAR
    TRAPMAN, J
    BRINKMANN, AO
    BOERSMA, WJA
    MULDER, E
    SCHROEDER, FH
    CLAASSEN, E
    VANDERKWAST, TH
    JOURNAL OF PATHOLOGY, 1990, 160 (04): : 329 - 332
  • [23] Luminal contents of benign and malignant prostatic glands: Correspondence to altered secretary mechanisms
    Cohen, RJ
    McNeal, JE
    Redmond, SL
    Meehan, K
    Thomas, R
    Wilce, M
    Dawkins, HJS
    HUMAN PATHOLOGY, 2000, 31 (01) : 94 - 100
  • [24] TISSUE-CULTURE GROWTH PATTERNS OF BENIGN AND MALIGNANT HUMAN PROSTATIC GLANDS
    TANNENBAUM, M
    BEMBRY, J
    FEDERATION PROCEEDINGS, 1973, 32 (MAR) : 857 - +
  • [25] Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy
    Reuter, VE
    UROLOGY, 1997, 49 (3A) : 16 - 22
  • [26] Androgen Receptor CAG Repeat Length and Risk of Biliary Tract Cancer and Stones
    Meyer, Tamra E.
    O'Brien, Thomas G.
    Andreotti, Gabriella
    Yu, Kai
    Li, Qizhai
    Gao, Yu-Tang
    Rashid, Asif
    Shen, Ming-Chang
    Wang, Bing-Sheng
    Han, Tian-Quan
    Zhang, Bai-He
    Niwa, Shelley
    Fraumeni, Joseph F., Jr.
    Hsing, Ann W.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (03) : 787 - 793
  • [27] The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
    Vickman, Renee E.
    Franco, Omar E.
    Moline, Daniel C.
    Vander Griend, Donald J.
    Thumbikat, Praveen
    Hayward, Simon W.
    ASIAN JOURNAL OF UROLOGY, 2020, 7 (03) : 191 - 202
  • [28] THE HETEROGENEITY OF BENIGN PROSTATIC HYPERPLASIA
    WALSH, PC
    JOURNAL OF UROLOGY, 1993, 150 (05): : 1587 - 1587
  • [29] Androgen Receptor CAG Repeat Length Is Not Associated With the Risk of Incident Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial
    Kristal, Alan R.
    Price, Douglas K.
    Till, Cathee
    Schenk, Jeannette M.
    Neuhouser, Marian L.
    Ockers, Sandy
    Lin, Daniel W.
    Thompson, Ian M.
    Figg, William D.
    PROSTATE, 2010, 70 (06): : 584 - 590
  • [30] IMMUNOHISTOCHEMISTRY OF THE ANDROGEN RECEPTOR IN HUMAN BENIGN AND MALIGNANT PROSTATE TISSUE
    MIYAMOTO, KK
    MCSHERRY, SA
    DENT, GA
    SAR, M
    WILSON, EM
    FRENCH, FS
    SHARIEF, Y
    MOHLER, JL
    JOURNAL OF UROLOGY, 1993, 149 (05): : 1015 - 1019
12345